ORIC – oric pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
ORIC® Pharmaceuticals Presents Potential Best-in-Class Profile for Enozertinib with Robust Systemic and CNS Activity in 1L and Previously Treated NSCLC Patients with EGFR Atypical Mutations at the ESMO Asia Congress 2025
ORIC® Pharmaceuticals Announces Enozertinib (ORIC-114) Late-Breaking Oral Presentations in EGFR Atypical and EGFR exon 20 NSCLC at the ESMO Asia Congress 2025
ORIC® Pharmaceuticals Announces Enozertinib (ORIC-114) Poster Presentation in HER2 exon 20 NSCLC at the ESMO Asia Congress 2025 [Yahoo! Finance]
ORIC® Pharmaceuticals Announces Enozertinib (ORIC-114) Poster Presentation in HER2 exon 20 NSCLC at the ESMO Asia Congress 2025
How New ORIC-944 Trial Results and Earnings Update Will Impact ORIC Pharmaceuticals (ORIC) Investors [Yahoo! Finance]
Form SCHEDULE 13G/A Oric Pharmaceuticals, Filed by: COLUMN GROUP II, LP
Form SCHEDULE 13G/A Oric Pharmaceuticals, Filed by: ALKEON CAPITAL MANAGEMENT LLC
Form 4 Oric Pharmaceuticals, For: Oct 06 Filed by: Piscitelli Dominic
Form 4 Oric Pharmaceuticals, For: Oct 06 Filed by: Chacko Jacob
Form 144 Oric Pharmaceuticals, Filed by: Piscitelli Dominic
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.